Strongyloidiasis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The drug of choice for the treatment of uncomplicated strongyloidiasis is ivermectin with albendazole as the alternative. All patients who are at risk of disseminated strongyloidiasis should be treated | The drug of choice for the treatment of uncomplicated strongyloidiasis is ivermectin with albendazole as the alternative. All patients who are at risk of disseminated strongyloidiasis should be treated.<ref>http://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm</ref> | ||
==Treatment== | ==Treatment== |
Revision as of 16:27, 5 June 2017
Strongyloidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Strongyloidiasis medical therapy On the Web |
American Roentgen Ray Society Images of Strongyloidiasis medical therapy |
Risk calculators and risk factors for Strongyloidiasis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The drug of choice for the treatment of uncomplicated strongyloidiasis is ivermectin with albendazole as the alternative. All patients who are at risk of disseminated strongyloidiasis should be treated.[1]
Treatment
Antimicrobial Regimen
- Strongyloides stercoralis
- Preferred regimen: Ivermectin 200 mcg/kg/day PO qd for 2 days or two doses 2 weeks apart from each other[2]
- Alternative regimen: Albendazole 400 mg PO bid for 3-7 days[3]
References
- ↑ http://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm
- ↑ "WGO Practice Guideline Management of Strongyloidiasis" (PDF).
- ↑ Archibald LK, Beeching NJ, Gill GV, Bailey JW, Bell DR (1993). "Albendazole is effective treatment for chronic strongyloidiasis". Q J Med. 86 (3): 191–5. PMID 8483992.